artera - Chief Medical Officer (CMO)

• Vision & Strategic Direction • Define and communicate a clear medical vision that aligns clinical opportunities with the company’s mission and commercial strategy. • Identify and prioritize clinical unmet needs with the greatest potential for patient benefit and market impact. • Serve as the primary medical spokesperson for the company with internal teams, investors, collaborators, and the broader oncology community. • Anticipate shifts in oncology practice, ensuring the company is positioned ahead of the curve. • Data & Collaborator Pipeline • Oversee strategies to build and maintain a high-quality, scalable clinical data pipeline that fuels product development, validation, and innovation. • Cultivate a strong network of academic partners, clinical collaborators, and key opinion leaders to advance the company’s scientific and commercial goals. • Ensure clinical evidence generation plans support both scientific credibility and payer adoption. • Cross-Functional Collaboration • Partner closely with product, R&D, and commercial teams to integrate clinical insight into portfolio strategy. • Translate complex clinical and scientific data into actionable business decisions. • Departmental Leadership • Lead teams to design, execute, and interpret clinical studies that support product development and to educate the clinical impact of the test with clinicians. • Lead team of physician leaders synthesizing collective clinical voice and expertise • ## Key Competencies: • Deep understanding of oncology practice, unmet needs, and pathways to adoption • Comes with a strong network of KOLs and research communities. • Experienced in developing and guiding programs spanning multiple tumor types • Visionary thinker who anticipates shifts in the clinical landscape and ensures research addresses the most impactful questions. • Skilled and persuasive communicator who inspires confidence across clinical, scientific, and business stakeholders. • Proven ability to build high-value partnerships and collaborative relationships to fuel a robust data pipeline as well as maintain strong relationships with influential groups, like guidelines committees. • Decisive leader who can cut through uncertainty, guide teams with clarity, and balance scientific rigor with business priorities. • Ensures the medical organization remains quick, nimble, and adaptable in a rapidly evolving oncology landscape